Previous Research: Endothelial Dysfunction-Impaired Insulin Resistance at the Cell Level

Kolka CM. Treating diabetes with exercise: focus on the microvasculature. J Diabetes Metab. 2013 Nov 16;4:308.

Kolka CM, Bergman RN. The endothelium in diabetes: its role in insulin access and diabetic complications. Rev Endocr Metab Disord. 2013;14(1):13-19.

Kolka CM, Bergman RN. The barrier within: endothelial transport of hormones. Physiology (Bethesda). 2012;27(4):237-247.

Kolka CM, Harrison LN, Lottati M, Chiu JD, Kirkman EL, Bergman RN. Diet induced obesity prevents interstitial dispersion of insulin in skeletal muscle. Diabetes. 2009;59(3):619-626.

Kolka CM, Rattigan S, Richards SM, Clark MG. Potential for endothelin-1-mediated impairment of contractile activity in hypertension. Clin Exp Pharmacol Physiol. 2007;34(3):217-222.

Kolka CM, Rattigan S, Richards SM, Barrett EJ, Clark MG. Endothelial Na+-D-glucose cotransporter: no role in insulin-mediated glucose uptake. Horm Metab Res. 2005;37(11):657-661.

Kolka CM, Rattigan S, Richards S, Clark MG. Metabolic and vascular actions of endothelin-1 are inhibited by insulin-mediated vasodilation in perfused rat hindlimb muscle. Br J Pharmacol. 2005;145(7):992-1000.

Chiu JD, Kolka CM, Richey JM, Harrison LN, Zuniga E, Kirkman EL, Bergman RN. Experimental hyperlipidemia dramatically reduces access of insulin to canine skeletal muscle. Obesity (Silver Spring). 2009;17(8):1486-1492.

Chiu JD, Richey JM, Harrison LN, Zuniga E, Kolka CM, Kirkman E, Ellmerer M, Bergman RN. Direct administration of insulin into skeletal muscle reveals that the transport of insulin across the capillary endothelium limits the time course of insulin to activate glucose disposal. Diabetes. 2008;57(4):828-835.

Back to research